Graves’ thyrotoxicosis in a patient with metastatic differentiated thyroid carcinoma and chronic lymphocytic leukaemia (CLL)
Journal Title: Archives of Medical Science - Year 2007, Vol 3, Issue 2
Abstract
Thyrotoxicosis is rare in patients with thyroid carcinoma. A case is reported of a 66-year-old woman with Graves’ disease, papillary thyroid carcinoma (PTC) with pulmonary metastases and chronic lymphocytic leukaemia (CLL). After thyroidectomy and antithyroid drug (ATD) withdrawal, thyrotoxicosis recurred. Treatment with ATD and 131I (six doses, 36.3 GBq in total) resulted in permanent hypothyroidism and significant destruction of lung metastases. The course of CLL was mild, but transient anaemia and thrombocytopenia were observed after 131I therapy. Pathomechanisms of thyrotoxicosis in patients with metastatic thyroid carcinoma, its treatment and its relation to CLL are presented.
Authors and Affiliations
Jacek Makarewicz, Sławomir Mikosiński, Antoni Rutkowski, Zbigniew Adamczewski, Andrzej Lewiński
Pitfalls in the management of hypocalcaemia: refractory hypocalcaemia after thyroidectomy not caused by postoperative hypoparathyroidism
Short-term lifestyle intervention significantly increases fasting adiponectin and induces a decline in serum adiponectin during oral glucose tolerance test, without changes in insulin resistance
Introduction: Metabolic syndrome is associated with insulin resistance (IR) and low concentrations of adiponectin, an adipocytokine that improves insulin sensitivity and has anti-inflammatory and anti-atherogenic propert...
Why the mother’s immune system does not reject her fetus
Toriello-Carey syndrome – a report of two new cases with additional findings
Rhabdomyolysis following severe hypokalemia caused by Conn’s syndrome
Rhabdomyolysis denotes a clinical and laboratory syndrome that results from a rapid breakdown of skeletal muscle cells. This releases potentially toxic muscle cell components into the circulation which may cause life-t...